CSTL

Castle Biosciences (CSTL)

Castle Biosciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CSTL

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/05	07 : 52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CSTL	Castle Biosciences Inc
2024/05/31	05 : 30	Business Wire	Castle Biosciences to Present New Data at 2024 ASCO® Annual Meeting Highlighting Use of DecisionDx®-Melanoma to Identify Early-Stage Melanoma Patients at High Risk of Metastasis to the Central Nervous System to Prompt Use of Imaging Surveillance	NASDAQ:CSTL	Castle Biosciences Inc
2024/05/30	05 : 44	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CSTL	Castle Biosciences Inc
2024/05/30	05 : 41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CSTL	Castle Biosciences Inc
2024/05/30	05 : 30	Business Wire	New Publication Shows DecisionDx®-SCC Identifies High-Risk Squamous Cell Carcinoma Patients Who Are Likely to Benefit from Adjuvant Radiation Therapy and Those Who Can Consider Deferring Treatment Based on Biological Risk of Metastasis	NASDAQ:CSTL	Castle Biosciences Inc
2024/05/29	05 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CSTL	Castle Biosciences Inc
2024/05/29	05 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CSTL	Castle Biosciences Inc
2024/05/29	05 : 13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CSTL	Castle Biosciences Inc
2024/05/29	05 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CSTL	Castle Biosciences Inc
2024/05/25	05 : 27	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CSTL	Castle Biosciences Inc
2024/05/15	20 : 00	Business Wire	Castle Biosciences to Present at the Leerink Partners Healthcare Crossroads Conference	NASDAQ:CSTL	Castle Biosciences Inc
2024/05/14	20 : 00	Business Wire	Castle Biosciences Expands Evidence Supporting the Performance of its TissueCypher® Barrett’s Esophagus Test in Predicting Future Development of Esophageal Cancer Through Multiple Data Presentations at DDW 2024	NASDAQ:CSTL	Castle Biosciences Inc
2024/05/11	04 : 14	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:CSTL	Castle Biosciences Inc
2024/05/10	20 : 00	Business Wire	Castle Biosciences’ IDgenetix® Test Receives 2024 MedTech Breakthrough Award for “Best Overall Mental Health Solution”	NASDAQ:CSTL	Castle Biosciences Inc
2024/05/09	05 : 30	Business Wire	Largest Prospective Study to Date Further Supports Performance of DecisionDx®-UM for Metastatic Risk Stratification in Uveal Melanoma and Utility of PRAME Biomarker for Refining Risk When Considered with DecisionDx-UM Class Result	NASDAQ:CSTL	Castle Biosciences Inc
2024/05/03	20 : 00	Business Wire	DecisionDx®-SCC Significantly Improves Prediction Accuracy of Metastatic Events after Mohs Surgery in New Study of Patients with High-Risk Cutaneous Squamous Cell Carcinoma Tumors of the Head and Neck	NASDAQ:CSTL	Castle Biosciences Inc
2024/05/03	05 : 05	Business Wire	Castle Biosciences Reports First Quarter 2024 Results	NASDAQ:CSTL	Castle Biosciences Inc
2024/05/01	05 : 30	Business Wire	Castle Biosciences Kicks off Skin Cancer Awareness Month with a Ribbon Cutting to Celebrate the City of Friendswood’s Designation as a Sun Safe Leadership Model City by IMPACT Melanoma	NASDAQ:CSTL	Castle Biosciences Inc
2024/04/11	20 : 00	Business Wire	Castle Biosciences to Release First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 2, 2024	NASDAQ:CSTL	Castle Biosciences Inc
2024/04/11	06 : 00	Business Wire	Castle Biosciences Celebrates Esophageal Cancer Awareness Month through Advocacy and Educational Collaborations	NASDAQ:CSTL	Castle Biosciences Inc
2024/04/10	20 : 00	Business Wire	Castle Biosciences’ Chief Financial Officer Frank Stokes Recognized as a Top CFO of Houston for Second Consecutive Year	NASDAQ:CSTL	Castle Biosciences Inc
2024/04/05	05 : 30	Business Wire	Presentations at EADO Highlight Potential Impact of Castle Biosciences’ DecisionDx®-Melanoma and DecisionDx®-SCC Tests on the Management of Patients with Skin Cancer	NASDAQ:CSTL	Castle Biosciences Inc
2024/04/02	20 : 00	Business Wire	Castle Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:CSTL	Castle Biosciences Inc
2024/03/28	06 : 00	Business Wire	Castle Biosciences Announces Updates to its Board of Directors	NASDAQ:CSTL	Castle Biosciences Inc
2024/03/25	20 : 00	Business Wire	Castle Biosciences Earns a Top Workplaces USA Award for the Third Consecutive Year	NASDAQ:CSTL	Castle Biosciences Inc
2024/03/23	05 : 30	Business Wire	Long-term Outcomes Data Shared at SSO 2024 Show That Patients with a Low-Risk DecisionDx®-Melanoma Test Result Were Recurrence Free at Three Years, Including Those Who Utilized the Test to Help Guide the Decision to Avoid an SLNB	NASDAQ:CSTL	Castle Biosciences Inc
2024/03/19	20 : 00	Business Wire	Leading Squamous Cell Carcinoma Practitioners Publish Consensus Guidelines Integrating DecisionDx®-SCC into a Clinical Workflow to Improve Decision-Making Regarding the Use of Adjuvant Radiation Therapy	NASDAQ:CSTL	Castle Biosciences Inc
2024/03/16	05 : 30	Business Wire	New Study Shows that the Drug-Drug Interactions and Lifestyle Factors Provided by Castle Biosciences’ IDgenetix® Test Significantly Improve Medication Recommendations Over Drug-Gene Interactions Alone for Patients 65 and Older	NASDAQ:CSTL	Castle Biosciences Inc
2024/03/12	20 : 00	Business Wire	Castle Biosciences to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum	NASDAQ:CSTL	Castle Biosciences Inc
2024/03/09	06 : 30	Business Wire	Castle Biosciences to Present New Data Highlighting the Clinical Value of its Dermatologic Tests for Patients with Skin Cancer at the 2024 American Academy of Dermatology (AAD) Annual Meeting	NASDAQ:CSTL	Castle Biosciences Inc